Abstract
Prostate cancer exhibits a lineage-specific dependence on androgen signaling. Castration resistance involves reactivation of androgen signaling or activation of alternative lineage programs to bypass androgen requirement. We describe an aberrant gastrointestinal-lineage transcriptome expressed in ∼5% of primary prostate cancer that is characterized by abbreviated response to androgen-deprivation therapy and in ∼30% of castration-resistant prostate cancer. This program is governed by a transcriptional circuit consisting of HNF4G and HNF1A. Cistrome and chromatin analyses revealed that HNF4G is a pioneer factor that generates and maintains enhancer landscape at gastrointestinal-lineage genes, independent of androgen-receptor signaling. In HNF4G/HNF1A-double-negative prostate cancer, exogenous expression of HNF4G at physiologic levels recapitulates the gastrointestinal transcriptome, chromatin landscape, and leads to relative castration resistance. Shukla et al. identify an aberrantly expressed gastrointestinal-lineage transcriptome governed by HNF4G and HNF1A in ∼30% of castration-resistant prostate cancer. HNF4G is a pioneer factor for this transcriptional program and its ectopic expression at physiologic levels reduces sensitivity to hormone deprivation.
Original language | English (US) |
---|---|
Pages (from-to) | 792-806.e7 |
Journal | Cancer Cell |
Volume | 32 |
Issue number | 6 |
DOIs | |
State | Published - Dec 11 2017 |
Keywords
- ChIP-seq
- HNF1A
- HNF4G
- SPINK1
- androgen-deprivation therapy
- castration resistance
- enzalutamide
- pioneer factor
- prostate cancer
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research